Review Article
Multimodal Liver-Directed Management of Neuroendocrine Hepatic Metastases
Table 1
Suggested eligibility criteria for resection of NET liver metastases.
| No miliary disease on preoperative liver imaging(MRI or multidetector CT) |
| Little to no extrahepatic disease on preoperative nuclear medicine studies | (18FF-DOPA PET preferred over octreotide scintigraphy for carcinoid) |
| Well- or moderately differentiated neuroendocrine carcinoma | (Ki-67 <20% and ideally, <15%) |
| Projected volume of residual functional liver >30% |
| No tumor necrosis |
|
|